Skip to content
Calculator
Evidence: LowPeptideDiscontinuedVasopressin analogueDiscontinued in the USNasal spray

Lypressin

The lysine form of vasopressin, once a nasal spray for diabetes insipidus

Lypressin is lysine vasopressin, the form of the antidiuretic hormone made by pigs. Sprayed into the nose, it controlled the excessive urination of diabetes insipidus, and was marketed in the US as Diapid. It has been discontinued there, superseded by longer-acting desmopressin.

Used in human trials: 5 or 10 IU, Not stated in the abstract, Intranasal (Study: pain thresholds in healthy volunteers) Details ↓

Overview

What is it?

Human vasopressin carries arginine at position 8; the pig hormone carries lysine. Synthetic 8-lysine vasopressin made it possible to treat diabetes insipidus with a nasal spray instead of injections. In a 1964 report of three patients, it gave excellent control in one and helped the other two alongside injected vasopressin tannate, but the well-controlled patient needed sprays every three hours during the day, which shows its short action.

That short action is why it was superseded: desmopressin, a modified vasopressin with a longer effect, replaced it. In the US, Diapid is listed as discontinued.

Lysine vasopressin has also been used as a diagnostic tool, and still is in some centres: given during sampling of the veins that drain the pituitary, it found the source of ACTH in all 29 patients with Cushing's syndrome in a 2018 Indian trial. Because vasopressin releases ACTH, it served as a stimulation test for the pituitary-adrenal axis: in patients with hypoadrenalism caused by hypothalamic disease, it raised ACTH in four of six, but not in patients with pituitary disease. Tested for pain relief in healthy people, intranasal lypressin produced no meaningful analgesia at doses that already caused water retention. Terlipressin, a modified lysine vasopressin, is broken down to it in the body.

8-lysine
Its difference from arginine vasopressin
lysine at position 8
29/29
Patients in whom sampling found the ACTH source
with CRH or lypressin · PMID 29440131
5 IU
Intranasal amount that already held water
healthy volunteers · PMID 3628176
Science

Mechanism of Action

Lypressin is 8-lysine vasopressin, a vasopressin with lysine in place of arginine at position 8, once sold as a nasal spray for diabetes insipidus.

💧

Water retention

In healthy volunteers, an intranasal amount too low to dull pain already produced a significant antidiuretic effect.

🧠

ACTH release

It raised plasma ACTH in 4 of 6 patients with hypothalamic disorders and in none with pituitary disease, and during petrosal sinus sampling it located the ACTH source in every patient with Cushing's syndrome.

🩸

Clotting factors

Infused in 8 patients with cirrhosis it raised factor VIII and plasminogen activator, which triglycyl lysine vasopressin did not.

Evidence

Published Research

These studies were read from their PubMed abstracts: the 1964 nasal-spray trial and later clinical uses, mostly as a pituitary stimulation test. Much of the 1970s literature caught by its chemical name is synthesis work on modified vasopressin analogues, which are different compounds and are not cited here.

Human1964

Nasal spray for diabetes insipidus

Synthetic 8-lysine vasopressin nasal spray gave excellent control in one of three patients with diabetes insipidus, who needed sprays every three hours by day, and was a useful supplement to vasopressin tannate in the other two.

PMID: 14179526
Human1987

No pain relief in humans

Intranasal lypressin at doses that already produced a significant antidiuretic effect had no marked analgesic effect on ischaemic, thermal or dental pain in healthy volunteers.

PMID: 3628176
Human1990

Pituitary stimulation testing

In 10 patients with secondary hypoadrenalism, lysine vasopressin raised plasma ACTH in 4 of 6 with hypothalamic disorders and in none with pituitary disease or isolated ACTH deficiency.

PMID: 2169450
Human1980

Effects on clotting factors in cirrhosis

In 8 patients with cirrhosis, lysine vasopressin infusion raised factor VIII and plasminogen activator, while triglycyl lysine vasopressin did not; the latter was shown to be cleaved to lysine vasopressin in the body.

PMID: 6768567
Human2018

Locating the tumour in Cushing's

In 29 patients with ACTH-dependent Cushing's syndrome randomised to CRH, 5 U or 10 U lysine vasopressin during inferior petrosal sinus sampling, every agent identified the source of ACTH in all patients; 10 U lysine vasopressin pointed to the correct side of the pituitary in 6 of 7, with transient side effects similar across groups.

PMID: 29440131
Human1996

A dexamethasone-modified test

In 61 people, a lysine vasopressin test after overnight dexamethasone separated Cushing's disease from healthy controls with 96.0% sensitivity and 100% specificity; depressed and cushingoid subjects behaved like controls, and the abnormal pattern reversed after successful pituitary surgery.

PMID: 8759183
Human1968

When other preparations cause allergy

A 1968 JAMA report describes lypressin nasal spray as useful in patients allergic to other antidiuretic hormone preparations, which were then animal-derived. No abstract is posted on PubMed.

PMID: 5694174
Review1972

A 1972 drug bulletin

The Medical Letter reviewed lypressin (Diapid) alongside the other drugs then used for diabetes insipidus. No abstract is posted on PubMed.

PMID: 4648574
Human1967

Testing the pituitary-adrenal axis, 1967

A German study measured plasma corticosteroids during insulin-induced hypoglycaemia and examined lypressin's effect on hypothalamic-pituitary-adrenal function, an early use of the peptide as a stimulation test rather than a treatment. No abstract is posted on PubMed.

PMID: 4952929
Dosing

Dosing Data

The amounts below are as stated in the abstracts of published human studies.

These are study amounts, not recommendations. Lypressin holds water strongly: even the lower amount produced a significant antidiuretic effect. See a doctor before using any peptide.
ProtocolDoseFrequencyDurationRoute
Study: pain thresholds in healthy volunteers Human studyPMID 36281765 or 10 IUNot stated in the abstractNot stated in the abstractIntranasal
Study: petrosal sinus sampling in ACTH-dependent Cushing's syndrome (29 patients, randomised) Human studyPMID 294401315 or 10 unitsSingle dose during samplingOne procedureNot stated in the abstract

Educational information, not medical advice. Each dose above is tagged with its source: an approved label, a published human study, animal data, or amounts reported by users. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose. Full medical disclaimer.

Units, not weight
Lypressin is measured in international units, given into the nose or during a diagnostic procedure; there is no weight-based calculation.
Open Calculator →
For Buyers

What a Buyer Needs to Know

What is sold, how it is mixed, stored and taken, and what is known about its safety, quality and legal status. Each part names its source. Where we have none, it says unknown.

What is sold

Unknown: we hold no label and no published test that says what forms or vial sizes Lypressin is sold in. A vial's own label is a seller's claim, not a source.

Mixing a vial: a worked example

No worked example: none of the doses on this page is a fixed amount in mg or mcg injected under the skin or into a muscle (the routes given are: intranasal, not stated in the abstract). There is no home-mixing step to show. The reconstitution calculator does the arithmetic for any vial.

Source: the route and amount of each dose row in Dosing Data below.

Storage before and after mixing

Unknown: no label or published stability study on file says how to store Lypressin, before or after mixing. The mixing guide sets out the general rules, with their sources: keep a mixed vial in the fridge, and use it promptly, as the bacteriostatic water label says of any drug dissolved in it. The 28 days often quoted is the limit for an opened multiple-dose vial from a manufacturer, an outer limit set for sterility, not a time a mixed solution has been shown to keep. Nobody has published how long Lypressin stays intact once mixed.

How it is taken

As it was given in human studies: Intranasal (Not stated in the abstract; Study: pain thresholds in healthy volunteers); Not stated in the abstract (Single dose during sampling; Study: petrosal sinus sampling in ACTH-dependent Cushing's syndrome (29 patients, randomised)).

For injection technique, sites and needle disposal, see the mixing guide.

Source: Used in human trials: the route and frequency of each row in Dosing Data below.

What to expect, and when

How long it stays in the body: not established by a measurement cited on this entry.

How long the doses were given: Study: petrosal sinus sampling in ACTH-dependent Cushing's syndrome (29 patients, randomised): One procedure.

When effects appear: unknown; no source on this page gives a time to effect for Lypressin. Results reported in the studies are under Published Research.

Source: Used in human trials, the duration of each row in Dosing Data below.

Side effects, and when to stop or get help

From the Side Effects section: Water retention at antidiuretic doses; Short duration, requiring frequent sprays. Full list and cautions ↓

When to stop or get help: unknown; no label or trial on file sets rules for stopping Lypressin. Treat a severe or unexpected reaction as a reason to stop and see a doctor.

Source: the Side Effects section below (“From the studies above”).

Interactions

  • glibenclamide: decreased antidiuretic response to lysine vasopressin in healthy subjects
  • chlorpropamide, carbamazepine or clofibrate: after brief antidiuresis, a lysine vasopressin bolus caused increased water diuresis for 12-24 hours or longer in diabetes insipidus patients taking these drugs

Every peptide's record, with its source: the interaction matrix.

Source: human study, PMID 4216226; human study, PMID 1192687.

Checking what you bought

Unknown: no published independent test of Lypressin products is in our lab-results database yet, so how products sold under this name measure up is not known.

To read a certificate of analysis, paste it into the COA decoder. Trust & Verification explains what independent testing can and cannot show.

Legal status

US: Discontinued (Marketed in the US as Diapid (Novartis), NDA 016755). Sport: Unsettled (S0 may apply).

Country by country ↓ · Regulatory tracker

Source: this entry's approval status and the WADA Prohibited List, as in Legal Status below.

Safety

Side Effects & Contraindications

Reported Side Effects

From the studies above.

● Water retention at antidiuretic doses
● Short duration, requiring frequent sprays

Contraindications & Cautions

No current US label: the product is discontinued and DailyMed has no label (read October 3, 2026).

● Historical use only in the US
Questions

Frequently Asked Questions

?What is the difference between lypressin and vasopressin?

Lypressin has lysine at position 8, as in the pig hormone; human vasopressin has arginine. Both concentrate urine through the kidney's V2 receptors.

?Why was lypressin replaced?

Its effect was short, so patients needed frequent sprays; longer-acting desmopressin replaced it, and Diapid is discontinued in the US.

?Is lypressin related to terlipressin?

Yes. Terlipressin is triglycyl lysine vasopressin, which the body cleaves into lysine vasopressin.

?How well did lypressin control diabetes insipidus?

In a 1964 report of three patients, the nasal spray gave excellent control in one, who needed it every three hours during the day but not at night; in the other two it helped only as a supplement to injected vasopressin tannate.

?Does lypressin relieve pain?

No meaningful effect was found. In healthy volunteers, intranasal lypressin did not relieve ischaemic, thermal or dental pain at doses that already caused water retention, so the authors concluded it cannot be used for pain.

?Why was lysine vasopressin used in hormone testing?

Vasopressin stimulates ACTH release from the pituitary. In patients with low adrenal function, lysine vasopressin raised ACTH in most of those with hypothalamic disease but in none with pituitary disease, helping locate the problem.

Bibliography

References

  1. [fda] US FDA, Drugs@FDA (openFDA): DIAPID, NDA 016755 (Novartis), marketing status discontinued; no label on DailyMed. Read October 3, 2026.
  2. [pubmed] CHIRMAN SB, et al. "DIABETES INSIPIDUS. TREATMENT WITH 8-LYSINE VASOPRESSIN IN A NASAL SPRAY." Calif Med, 1964;101(1):1-3. PMID: 14179526.
  3. [pubmed] Kemppainen P, et al. "Human pain thresholds after the application of lypressin, a vasopressin analogue." Pharmacol Toxicol, 1987;61(1):16-9. PMID: 3628176.
  4. [pubmed] Cantalamessa L, et al. "CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders." Horm Metab Res, 1990;22(7):389-93. PMID: 2169450.
  5. [pubmed] Prowse CV, et al. "Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis." Eur J Clin Invest, 1980;10(1):49-54. PMID: 6768567.
  6. [pubmed] Jarial KDS, et al. "Diagnostic accuracy and comparison of BIPSS in response to lysine vasopressin and hCRH." Endocr Connect, 2018;7(3):425-432. PMID: 29440131.
  7. [pubmed] Contreras P, et al. "Overnight dexamethasone pre-treatment improves the performance of the lysine-vasopressin test in the diagnosis of Cushing's syndrome." Clin Endocrinol (Oxf), 1996;44(6):703-10. PMID: 8759183.
  8. [pubmed] Mimica N, et al. "Lypressin nasal spray. Usefulness in patients who manifest allergies to other antidiuretic hormone preparations." JAMA, 1968;203(9):802-3. PMID: 5694174.
  9. [pubmed] "Lypressin (Diapid) and other drugs for diabetes insipidus." Med Lett Drugs Ther, 1972;14(26):98-9. PMID: 4648574.
  10. [pubmed] Bethge H, et al. "[The state of plasma corticosteroids during insulin induced hypoglycemia and the effects of lypressin on the function of the hypothalamo-pituitary-adrenal axis]." Acta Endocrinol (Copenh), 1967;55(4):622-36. PMID: 4952929.
  11. [pubmed] Simionescu S. "[The activating role of antidiuretic hormone (8-lysine-vasopressin) in the mechanism of equilibration of the functions of the body]." Physiologie, 1977;14(2):95-100. PMID: 405692.
  12. [pubmed] Larsson LE, et al. "Synthesis of O-alkylated lysine-vasopressins, inhibitors of the antidiuretic response to lysine-vasopressin." J Med Chem, 1978;21(4):352-6. PMID: 650663.
  13. [pubmed] Krishna NR, et al. "Amide hydrogen exchange rates of peptides in H2O solution by 1H nuclear magnetic resonance transfer of solvent saturation method. Conformations of oxytocin and lysine vasopressin in aqueous solution." Biophys J, 1979;26(3):345-66. PMID: 262422.
  14. [pubmed] Roy C, et al. "Characterization of (8-lysine) vasopressin binding sites on a pig kidney cell line (LLC-PK1). Evidence for hormone-induced receptor transition." J Biol Chem, 1981;256(7):3415-22. PMID: 6259166.
  15. [pubmed] Roy C, et al. "Relationship of (8-lysine) vasopressin receptor transition to receptor functional properties in a pig kidney cell line (LLC-PK1)." J Biol Chem, 1981;256(7):3423-7. PMID: 6162846.
  16. [pubmed] Skopková J, et al. "Comparison of antidiuretic and natriuretic effects of [8-lysine]vasopressin and [8-D-arginine]deaminovasopressin in conscious rats." Endocrinol Exp, 1981;15(2):129-38. PMID: 6973460.
  17. [pubmed] Janáky T, et al. "Biological half-lives and organ distribution of tritiated 8-lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin in Brattleboro rats." Ann N Y Acad Sci, 1982;394:116-27. PMID: 6960751.
  18. [pubmed] Boulétreau P, et al. "[Effects of a postpituitary extract and lysine vasopressin on portal and systemic hemodynamics in the cirrhotic patient]." Gastroenterol Clin Biol, 1984;8(3):255-9. PMID: 6714560.
  19. [pubmed] Kochar MS. "Hemodynamic effects of lysine-vasopressin in orthostatic hypotension." Am J Kidney Dis, 1985;6(1):49-52. PMID: 4025327.
  20. [pubmed] Szadowska A, et al. "The effect of 6-hydroxydopamine and some hypotensive drugs on lypressin induced hypertension in rats." Pol J Pharmacol Pharm, 1985;37(4):487-93. PMID: 3936030.
  21. [pubmed] Leitold M, et al. "[Influence of antianginal drugs on Lypressin induced T-wave enhancement in the electrocardiogram of the rat]." Arzneimittelforschung, 1986;36(10):1454-7. PMID: 2949754.
  22. [pubmed] Gorbulev V, et al. "Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line." Eur J Biochem, 1993;215(1):1-7. PMID: 8393786.
  23. [pubmed] Iida K, et al. "Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide." Clin Endocrinol (Oxf), 1997;47(6):739-45. PMID: 9497882.
  24. [pubmed] Horiba N, et al. "[Lysine-vasopressin test]." Nihon Rinsho, 1997;55 Suppl 2:272-4. PMID: 9172525.
  25. [pubmed] Coiro V, et al. "Enhancement of the GH responsiveness to GH releasing stimuli by lysine vasopressin in type 1 diabetic subjects." Clin Endocrinol (Oxf), 1999;51(4):487-95. PMID: 10583317.
  26. [pubmed] Parrott RF, et al. "Intravenous lysine vasopressin lowers body temperature in normal and febrile pigs." Peptides, 1999;20(6):753-9. PMID: 10477132.
  27. [pubmed] Pedersen OS, et al. "The effect of arginine vasopressin, lysine vasopressin or oxytocin on ADP or arginine vasopressin-induced Ca2+ increase in human platelets." Clin Physiol, 1999;19(4):305-10. PMID: 10451791.
  28. [pubmed] Eames P, et al. "Lysine vasopressin in post-traumatic memory disorders: an uncontrolled pilot study." Brain Inj, 1999;13(4):255-60. PMID: 10230526.
  29. [pubmed] Braileanu GT, et al. "Effects of arginine- and lysine-vasopressin on phospholipase C activity, intracellular calcium concentration and prostaglandin F2alpha secretion in pig endometrial cells." Reproduction, 2001;121(4):605-12. PMID: 11277881.
  30. [pubmed] D'Eath RB, et al. "Resident-intruder trait aggression is associated with differences in lysine vasopressin and serotonin receptor 1A (5-HT1A) mRNA expression in the brain of pre-pubertal female domestic pigs (Sus scrofa)." J Neuroendocrinol, 2005;17(10):679-86. PMID: 16159381.
  31. [pubmed] Westphal M, et al. "Terlipressin--more than just a prodrug of lysine vasopressin?." Crit Care Med, 2009;37(3):1135-6. PMID: 19237933.
  32. [pubmed] Mégarbané H, et al. "Two observations raising questions about risk factors of cutaneous necrosis induced by terlipressin (Glypressin)." Dermatology, 2009;218(4):334-7. PMID: 19155616.
  33. [pubmed] Bianco G, et al. "Structural characterization of arginine-vasopressin and lysine-vasopressin by Fourier- transform ion cyclotron resonance mass spectrometry and infrared multiphoton dissociation." Eur J Mass Spectrom (Chichester), 2015;21(3):211-9. PMID: 26307701.

Sources & Citations

Studies were read from their PubMed records; regulatory sources are listed below, read October 3, 2026.

Medical Disclaimer: This content is for educational and informational purposes only. It is not medical advice, and nothing here is an instruction to obtain or use any compound. Talk to a licensed clinician about your own situation.

Last reviewed: 2026-10-19